Veritas Buys Curoverse to Bring AI Analysis of Genes to the Masses – Xconomy


Xconomy

Veritas Buys Curoverse to Bring AI Analysis of Genes to the Masses
Xconomy
Veritas, a Boston startup, has already made genetic analysis more affordable by bringing the cost of whole genome sequencing below $1,000. But to reach the future that Martinez envisions, the company needs the capability to go beyond the hundreds of …
Veritas Genetics Acquires Curoverse to Deploy Large-Scale Artificial Intelligence and Machine Learning in GenomicsPR Newswire (press release)

all 3 news articles »

Source: Genome Sequencing